233
Views
204
CrossRef citations to date
0
Altmetric
Research Article

Screening for Hemochromatosis: High Prevalence and Low Morbidity in an Unselected Population of 65,238 Persons

Pages 1108-1115 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (18)

Henrik Frederiksen. (2019) Dehydrated hereditary stomatocytosis: clinical perspectives. Journal of Blood Medicine 10, pages 183-191.
Read now
Ketil Thorstensen, Mona A. Kvitland, Wenche Ø. Irgens, Arne Åsberg, Berit Borch-Iohnsen, Torolf Moen & Kristian Hveem. (2017) Iron loading in HFE p.C282Y homozygotes found by population screening: relationships to HLA-type and T-lymphocyte subsets. Scandinavian Journal of Clinical and Laboratory Investigation 77:7, pages 477-485.
Read now
Einar S. Björnsson & Anders Ekbom. (2015) Scandinavian epidemiological research in gastroenterology and hepatology. Scandinavian Journal of Gastroenterology 50:6, pages 636-648.
Read now
ARNE Åsberg, Ketil Thorstensen, Wenche ø. Irgens, PÅl R. Romundstad & Kristian Hveem. (2013) Cancer risk in HFE C282Y homozygotes: results from the HUNT 2 study. Scandinavian Journal of Gastroenterology 48:2, pages 189-195.
Read now
Jonas F. Ludvigsson, Joseph A. Murray, Paul C. Adams & Maria Elmberg. (2013) Does hemochromatosis predispose to celiac disease? A study of 29,096 celiac disease patients. Scandinavian Journal of Gastroenterology 48:2, pages 176-182.
Read now
Soo Aleman, Sanam Endalib, Per Stål, Lars Lööf, Stefan Lindgren, Hanna Sandberg-Gertzén, Sven Almer, Sigvard Olsson, Åke Danielsson, Sven Wallerstedt & Rolf Hultcrantz. (2011) Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population. Scandinavian Journal of Gastroenterology 46:9, pages 1118-1126.
Read now
Ann R. Broderstad, Tone Smith-Sivertsen, Inger Marie Dahl, Ole Christian Ingebretsen & Eiliv Lund. (2011) Low prevalence of hereditary hemochromatosis in multiethnic populations in Northern Norway. Scandinavian Journal of Gastroenterology 46:3, pages 350-357.
Read now
Ketil Thorstensen, Mona A. Kvitland, Wenche Ø. Irgens, Kristian Hveem & Arne Åsberg. (2010) Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation. Scandinavian Journal of Clinical and Laboratory Investigation 70:2, pages 92-97.
Read now
Eng K Gan, Debbie Trinder, Oyekoya T Ayonrinde & John K Olynyk. (2009) Genetics of hereditary hemochromatosis: a clinical perspective. Expert Review of Endocrinology & Metabolism 4:3, pages 225-239.
Read now
Einar Skulstad Davidsen, Per Omvik, Tor Hervig & Eva Gerdts. (2009) Left ventricular diastolic function in patients with treated haemochromatosis. Scandinavian Cardiovascular Journal 43:1, pages 32-38.
Read now
Enrico Rossi, John K Olynyk & Gary P Jeffrey. (2008) Clinical penetrance of C282Y homozygous HFE hemochromatosis. Expert Review of Hematology 1:2, pages 205-216.
Read now
Yves Deugnier & Jean Mosser. (2008) Modifying factors of the HFE hemochromatosis phenotype. Expert Review of Gastroenterology & Hepatology 2:4, pages 531-540.
Read now
Oyekoya T. Ayonrinde, Elizabeth A. Milward, Anita C. G. Chua, Debbie Trinder & John K. Olynyk. (2008) Clinical Perspectives on Hereditary Hemochromatosis. Critical Reviews in Clinical Laboratory Sciences 45:5, pages 451-484.
Read now
Arne Åsberg, Kristian Hveem, Kjell Kannelønning & Wenche Øiestad Irgens. (2007) Penetrance of the C28Y/C282Y genotype of the HFE gene. Scandinavian Journal of Gastroenterology 42:9, pages 1073-1077.
Read now
Arne Åsberg, Kristian Hveem, Tore B. Halvorsen & Hanne-Brit G. Smethurst. (2007) Prevalence of liver fibrosis and cirrhosis in screening-detected C282Y homozygous subjects. Scandinavian Journal of Gastroenterology 42:6, pages 782-783.
Read now
Jan Aaseth, Trond Peder Flaten & Ole Andersen. (2007) Hereditary iron and copper deposition: Diagnostics, pathogenesis and therapeutics. Scandinavian Journal of Gastroenterology 42:6, pages 673-681.
Read now
S. Distante. (2006) Genetic predisposition to iron overload: Prevalence and phenotypic expression of hemochromatosis‐associated HFE‐C282Y gene mutation. Scandinavian Journal of Clinical and Laboratory Investigation 66:2, pages 83-100.
Read now
B. Borch‐Iohnsen, B. Sandstad & A. Åsberg. (2005) Iron status among 3005 women aged 20–55 years in Central Norway: The Nord‐Trøndelag Health Study (the HUNT Study). Scandinavian Journal of Clinical and Laboratory Investigation 65:1, pages 45-54.
Read now

Articles from other publishers (186)

Malvina Hoxha, Visar Malaj & Bruno Zappacosta. (2024) Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review. PharmacoEconomics - Open 8:2, pages 147-170.
Crossref
Alexandr Parlesak, Talia Theresa Masino, Kia Daniela Reis, Caroline Filskov Petersen, Jacob Juel Christensen, Thomas Olsen & Inge Tetens. (2024) Preparatory work for the update of the tolerable upper intake levels for iron. EFSA Supporting Publications 21:2.
Crossref
Gulzar Ahmed, Sushma Rathi, Harmandeep K. Sidhu, Momil Muzaffar, Muhammad H. Wajid, Komal Kumari, Hajar Fakhor, Nada M. Attia, Koushik Majumder, Vikash Kumar, Usha Tejwaney & Nanik Ram. (2024) Paroxysmal atrial fibrillation and hemochromatosis: a narrative review. Annals of Medicine & Surgery 86:2, pages 909-919.
Crossref
Mazyar Yazdani, Sonia Distante, Lars Mørkrid, Rune J. Ulvik & Bjørn J. Bolann. (2022) Bloodlettings in Hemochromatosis Result in Increased Blood Lead (Pb) Concentrations. Biological Trace Element Research 201:7, pages 3193-3201.
Crossref
Ahmad Abou Yassine, Kira MacDougall, Roula Sasso, Youssef Shammaa, Mira Alsheikh, Mohammad Abureesh, Loai Dahabra, Mohammad Alshami & Stephen Mulrooney. (2023) The Evolution of Iron-Related Comorbidities and Hospitalization in Patients with Hemochromatosis: An Analysis of the Nationwide Inpatient Sample. Blood Science Publish Ahead of Print.
Crossref
Jörg Schmidtke. (2022) Twenty-Five Years of Contemplating Genotype-Based Hereditary Hemochromatosis Population Screening. Genes 13:9, pages 1622.
Crossref
Ulrike Baschant, Sandro Altamura, Peter Steele-Perkins, Martina U. Muckenthaler, Maja Vujić Spasić, Lorenz C. Hofbauer, Andrea U. Steinbicker & Martina Rauner. (2022) Iron effects versus metabolic alterations in hereditary hemochromatosis driven bone loss. Trends in Endocrinology & Metabolism 33:9, pages 652-663.
Crossref
Lauren Andersson, Lawrie W. Powell, Louise E. Ramm, Grant A. Ramm & John K. Olynyk. (2022) Arthritis Prediction of Advanced Hepatic Fibrosis in HFE Hemochromatosis. Mayo Clinic Proceedings 97:9, pages 1649-1655.
Crossref
James C. Barton, J. Clayborn Barton, Neha Patel & Gordon D. McLaren. (2021) Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review. PLOS ONE 16:12, pages e0261690.
Crossref
Miriam Sandnes, Marta Vorland, Rune J. Ulvik & Håkon Reikvam. (2021) HFE Genotype, Ferritin Levels and Transferrin Saturation in Patients with Suspected Hereditary Hemochromatosis. Genes 12:8, pages 1162.
Crossref
Hannes Hagström, Nelson Ndegwa, Molly Jalmeus, Mattias Ekstedt, Iris Posserud, Fredrik Rorsman, Nils Nyhlin, Daniel Klintman, Mårten Werner, Hanns‐Ulrich Marschall, Johan Askling & Per Stål. (2021) Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers . Liver International 41:3, pages 545-553.
Crossref
Heidi Kristine Grønlien, Trine Eker Christoffersen, Camilla Furlund Nystrand, Lamya Garabet, Terje Syvertsen, Morten K. Moe, Ole Kristoffer Olstad & Christine Monceyron Jonassen. (2021) Cytokine and Gene Expression Profiling in Patients with <b><i>HFE</i></b>-Associated Hereditary Hemochromatosis according to Genetic Profile. Acta Haematologica 144:4, pages 446-457.
Crossref
Dan-Dan Ruan, Yu-Mian Gan, Tao Lu, Xiao Yang, Yao-Bin Zhu, Qing-Hua Yu, Li-Sheng Liao, Ning Lin, Xin Qian, Jie-Wei Luo & Fa-Qiang Tang. (2020) Genetic diagnosis history and osteoarticular phenotype of a non-transfusion secondary hemochromatosis. World Journal of Clinical Cases 8:23, pages 5962-5975.
Crossref
Dan-Dan Ruan, Yu-Mian Gan, Tao Lu, Xiao Yang, Yao-Bin Zhu, Qing-Hua Yu, Li-Sheng Liao, Ning Lin, Xin Qian, Jie-Wei Luo & Fa-Qiang Tang. (2020) Genetic diagnosis history and osteoarticular phenotype of a non-transfusion secondary hemochromatosis. World Journal of Clinical Cases 8:23, pages 5959-5972.
Crossref
Ondřej Groborz, Lenka Poláková, Kristýna Kolouchová, Pavel Švec, Lenka Loukotová, Vijay Madhav Miriyala, Pavla Francová, Jan Kučka, Jan Krijt, Petr Páral, Martin Báječný, Tomáš Heizer, Radek Pohl, David Dunlop, Jiří Czernek, Luděk Šefc, Jiří Beneš, Petr Štěpánek, Pavel Hobza & Martin Hrubý. (2020) Chelating Polymers for Hereditary Hemochromatosis Treatment. Macromolecular Bioscience 20:12.
Crossref
Carl Eckerström, Sofia Frändberg, Lena Lyxe, Cecilia Pardi & Jan Konar. (2020) Evaluation of a screening program for iron overload andHFE mutations in 50,493 blood donors. Annals of Hematology 99:10, pages 2295-2301.
Crossref
Sigbjørn Berentsen, Wilma BarcelliniShirley D’SaUlla RandenTor Henrik Anderson TvedtBruno Fattizzo, Einar HaukåsMegan KellRobert BrudevoldAnders E. A. DahmJakob DalgaardHege FrøenRandi Fykse Hallstensen, Pernille H. Jæger, Henrik Hjorth-Hansen, Agnieszka MałeckaMarkku OksmanJürgen RolkeMallika SekharJon Hjalmar Sørbø, Eirik Tjønnfjord, Galina TsykunovaGeir E. Tjønnfjord. (2020) Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood 136:4, pages 480-488.
Crossref
Martin Hanna, Michael Fogarty, Clodagh Loughrey, Anthony Thompson, Christine Macartney, Andrew Thompson & Ben McNaughten. (2019) How to use… iron studies. Archives of disease in childhood - Education & practice edition 104:6, pages 321-327.
Crossref
Mark J.W. McPhail, Shirin E. Khorsandi, Laura Abbott, Gillian Al-Kadhimi, Pauline Kane, John Karani, John O’Grady, Nigel Heaton, Adrian Bomford & Abid Suddle. (2019) Modern Outcomes Following Treatment of Hepatocellular Carcinoma in Hereditary Hemochromatosis. American Journal of Clinical Oncology 42:12, pages 918-923.
Crossref
Jad A. Baki & Elliot B. Tapper. (2019) Contemporary Epidemiology of Cirrhosis. Current Treatment Options in Gastroenterology 17:2, pages 244-253.
Crossref
Steven A. Bloomer & Kyle E. Brown. (2019) Iron-Induced Liver Injury: A Critical Reappraisal. International Journal of Molecular Sciences 20:9, pages 2132.
Crossref
Gary P. Jeffrey & Paul C. Adams. 2019. Evidence‐based Gastroenterology and Hepatology 4e. Evidence‐based Gastroenterology and Hepatology 4e 547 553 .
Luke C Pilling, Jone Tamosauskaite, Garan Jones, Andrew R Wood, Lindsay Jones, Chai-Ling Kuo, George A Kuchel, Luigi Ferrucci & David Melzer. (2019) Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank. BMJ, pages k5222.
Crossref
Marinos Pericleous, Claire Kelly, Aftab Ala & Michael L. Schilsky. 2019. Clinical Epidemiology of Chronic Liver Diseases. Clinical Epidemiology of Chronic Liver Diseases 307 330 .
Albina Nowak, Rebekka S. Giger & Pierre-Alexandre Krayenbuehl. (2018) Higher age at diagnosis of hemochromatosis is the strongest predictor of the occurrence of hepatocellular carcinoma in the Swiss hemochromatosis cohort. Medicine 97:42, pages e12886.
Crossref
Maja Krzewińska, Anna Kjellström, Torsten Günther, Charlotte Hedenstierna-Jonson, Torun Zachrisson, Ayça Omrak, Reyhan Yaka, Gülşah Merve Kılınç, Mehmet Somel, Veronica Sobrado, Jane Evans, Corina Knipper, Mattias Jakobsson, Jan Storå & Anders Götherström. (2018) Genomic and Strontium Isotope Variation Reveal Immigration Patterns in a Viking Age Town. Current Biology 28:17, pages 2730-2738.e10.
Crossref
Edward J. Fitzsimons, Jonathan O. Cullis, Derrick W. Thomas, Emmanouil Tsochatzis & William J. H. Griffiths. (2018) Diagnosis and therapy of genetic haemochromatosis (review and 2017 update). British Journal of Haematology 181:3, pages 293-303.
Crossref
Barbara de Graaff, Amanda Neil, Lei Si, Kwang Chien Yee, Kristy Sanderson, Lyle Gurrin & Andrew J. Palmer. (2016) Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia. Applied Health Economics and Health Policy 15:4, pages 521-534.
Crossref
Sergio A. Sánchez‐Luna & Kyle E. Brown. (2017) Clinical burden of liver disease from hemochromatosis at an academic medical center. Hepatology Communications 1:5, pages 453-459.
Crossref
James C. Barton, Wen-pin Chen, Mary J. Emond, Pradyumna D. Phatak, V. Nathan Subramaniam, Paul C. Adams, Lyle C. Gurrin, Gregory J. Anderson, Grant A. Ramm, Lawrie W. Powell, Katrina J. Allen, John D. Phillips, Charles J. Parker, Gordon D. McLaren & Christine E. McLaren. (2017) GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes. Blood Cells, Molecules, and Diseases 63, pages 15-20.
Crossref
Barbara de Graaff, Lei Si, Amanda L. Neil, Kwang Chien Yee, Kristy Sanderson, Lyle C. Gurrin & Andrew J. Palmer. (2016) Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model. PharmacoEconomics - Open 1:1, pages 37-51.
Crossref
Rawan Eid, Nagla T.T. Arab & Michael T. Greenwood. (2017) Iron mediated toxicity and programmed cell death: A review and a re-examination of existing paradigms. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1864:2, pages 399-430.
Crossref
James C. Barton & Ronald T. Acton. (2017) Diabetes in HFE Hemochromatosis . Journal of Diabetes Research 2017, pages 1-16.
Crossref
Gaye Cunnane. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology 1997 2006 .
Barbara de Graaff, Amanda Neil, Kristy Sanderson, Kwang Chien Yee & Andrew J. Palmer. (2016) Quality of life utility values for hereditary haemochromatosis in Australia. Health and Quality of Life Outcomes 14:1.
Crossref
Lawrie W Powell, Rebecca C Seckington & Yves Deugnier. (2016) Haemochromatosis. The Lancet 388:10045, pages 706-716.
Crossref
Barbara de Graaff, Amanda Neil, Kristy Sanderson, Lei Si, Kwang Chien Yee & Andrew J. Palmer. (2015) A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis. Applied Health Economics and Health Policy 13:5, pages 469-483.
Crossref
Bjørn J. Bolann, Sonia Distante, Lars Mørkrid & Rune J. Ulvik. (2015) Bloodletting therapy in hemochromatosis: Does it affect trace element homeostasis?. Journal of Trace Elements in Medicine and Biology 31, pages 225-229.
Crossref
Seongseok Yun & Nicole D. Vincelette. (2015) Update on iron metabolism and molecular perspective of common genetic and acquired disorder, hemochromatosis. Critical Reviews in Oncology/Hematology 95:1, pages 12-25.
Crossref
Catherine Ogilvie, Dairena Gaffney, Heather Murray, Andrew Kerry, Caroline Haig, Richard Spooner & Edward J Fitzsimons. (2015) Improved detection of hereditary haemochromatosis. Journal of Clinical Pathology 68:3, pages 218-221.
Crossref
Dilum Ekanayake, Clinton Roddick, Murtaza Khanbhai & Lawrie W. Powell. (2015) Homozygosity For The C282Y Substitution In The HFE Gene: The Incomplete Penetrance And Variable Expressivity. EMJ Hepatology, pages 79-85.
Crossref
Seyed Ali Mousavi, Faiza Mahmood, Astrid Aandahl, Teresa Risopatron Knutsen & Abid Hussain Llohn. (2015) Relationship of Baseline Hemoglobin Level with Serum Ferritin, Postphlebotomy Hemoglobin Changes, and Phlebotomy Requirements among HFE C282Y Homozygotes . BioMed Research International 2015, pages 1-9.
Crossref
Elena M. Massarotti. 2015. Rheumatology. Rheumatology 1628 1632 .
Seung-Min Lee, Alexandre Loguinov, Robert E. Fleming & Christopher D. Vulpe. (2014) Effects of strain and age on hepatic gene expression profiles in murine models of HFE-associated hereditary hemochromatosis. Genes & Nutrition 10:1.
Crossref
Gioconda Dias Rodrigues Leão, Juliana Mendonça Freire, Andrea Luciana Araújo Cunha Fernandes, Taissa Maria Moura de Oliveira, Nilma Dias Leão, Erica Aires Gil, Roberto Chaves de Vasconcelos, João Paulo da Silva Azevedo, Valéria Soraya de Farias Sales, Telma Maria de Araújo Moura Lemos, Marcos Dias Leão, Francisco Fernandes do NascimentoJrJr, James Farley Rafael Maciel, Rodrigo Villar de Freitas, Aldair de Souza Paiva & Geraldo Barroso CavalcantiJr.Jr.. (2014) Analysis of HFE Genes C282Y, H63D, and S65D in Patients With Hyperferritinemia From Northeastern Brazil. Journal of Clinical Laboratory Analysis 28:3, pages 178-185.
Crossref
Lachlan RO Ayres, Vanoo Jayasekeran & John K Olynyk. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Susan F. Leitman. (2013) Hemochromatosis: the new blood donor. Hematology 2013:1, pages 645-650.
Crossref
Mónica Costa, Eugénia Cruz, James C. Barton, Ketil Thorstensen, Sandra Morais, Berta M. da Silva, Jorge P. Pinto, Cristina P. Vieira, Jorge Vieira, Ronald T. Acton & Graça Porto. (2013) Effects of Highly Conserved Major Histocompatibility Complex (MHC) Extended Haplotypes on Iron and Low CD8+ T Lymphocyte Phenotypes in HFE C282Y Homozygous Hemochromatosis Patients from Three Geographically Distant Areas. PLoS ONE 8:11, pages e79990.
Crossref
Simon Mitchell & Pedro Mendes. (2013) A Computational Model of Liver Iron Metabolism. PLoS Computational Biology 9:11, pages e1003299.
Crossref
James C. Barton. (2013) Hemochromatosis and Iron Overload: From Bench to Clinic. The American Journal of the Medical Sciences 346:5, pages 403-412.
Crossref
Katja Frenzen, Christoph Schäfer & Gernot Keyßer. (2013) Erosive and inflammatory joint changes in hereditary hemochromatosis arthropathy detected by low-field magnetic resonance imaging. Rheumatology International 33:8, pages 2061-2067.
Crossref
Kaveh Hoda, Christopher L. Bowlus, Thomas W. Chu & Jeffrey R. Gruen. 2013. Emery and Rimoin's Principles and Practice of Medical Genetics. Emery and Rimoin's Principles and Practice of Medical Genetics 1 41 .
Trond Peder Flaten, Jan Aaseth, Ole Andersen & George J. Kontoghiorghes. (2012) Iron mobilization using chelation and phlebotomy. Journal of Trace Elements in Medicine and Biology 26:2-3, pages 127-130.
Crossref
Kim Ekblom, Stefan L. Marklund, Richard Palmqvist, Bethany Van Guelpen, Göran Hallmans, Lars Weinehall & Johan Hultdin. (2012) Iron Biomarkers in Plasma, HFE Genotypes, and the Risk for Colorectal Cancer in a Prospective Setting. Diseases of the Colon & Rectum 55:3, pages 337-344.
Crossref
Itty M. Nadakkavukaran, Eng K. Gan & John K. Olynyk. (2012) Screening for hereditary haemochromatosis. Pathology 44:2, pages 148-152.
Crossref
Sigbjørn Berentsen. (2012) Jernkelering ved myelodysplastisk syndrom. Tidsskrift for Den norske legeforening 132:17, pages 1972-1973.
Crossref
Paul C. Adams. 2012. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 1127 1144 .
Richard Skoien & Lawrie W. Powell. 2012. Iron Physiology and Pathophysiology in Humans. Iron Physiology and Pathophysiology in Humans 385 398 .
Bruce R. Bacon & Robert S. Britton. 2011. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver 825 844 .
Bjørn MørkedalLars E LaugsandPål R RomundstadLars J Vatten. (2011) Mortality from ischaemic heart disease: sex-specific effects of transferrin saturation, serum iron, and total iron binding capacity. The HUNT study. European Journal of Cardiovascular Prevention & Rehabilitation 18:5, pages 687-694.
Crossref
Bruce R. Bacon, Paul C. Adams, Kris V. Kowdley, Lawrie W. Powell & Anthony S. Tavill. (2011) Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases. Hepatology 54:1, pages 328-343.
Crossref
Paul Adams. 2011. Sherlock's Diseases of the Liver and Biliary System. Sherlock's Diseases of the Liver and Biliary System 521 533 .
Sandra Milic, Smiljana Ristic, Nada Starcevic-Cizmarevic, Bojana Brajenovic-Milic, Marija Crnic-Martinovic, Miljenko Kapovic, Borut Peterlin & Davor Stimac. (2011) Low frequency of HFE gene mutations in Croatian patients suspected of having hereditary hemochromatosis. Medical Science Monitor 17:10, pages CR552-CR556.
Crossref
Elena M. Massarotti. 2011. Rheumatology. Rheumatology 1929 1933.e1 .
Fei Jin, Li-Shuai Qu & Xi-Zhong Shen. (2010) Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis. Journal of Experimental & Clinical Cancer Research 29:1.
Crossref
Gary P Jeffrey & Paul C Adams. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology 484 492 .
J. Rochette, G. Le Gac, K. Lassoued, C. Férec & K. J. H. Robson. (2010) Factors influencing disease phenotype and penetrance in HFE haemochromatosis. Human Genetics 128:3, pages 233-248.
Crossref
Anne S. Røsvik, Rune J. Ulvik, Tore Wentzel‐Larsen & Tor Hervig. (2010) Blood donors with hereditary hemochromatosis. Transfusion 50:8, pages 1787-1793.
Crossref
Paul C. Adams & James C. Barton. (2010) How I treat hemochromatosis. Blood 116:3, pages 317-325.
Crossref
James C. Barton, Corwin Q. Edwards, Pradyumna D. Phatak, Robert S. Britton & Bruce R. BaconJames C. Barton, Corwin Q. Edwards, Pradyumna D. Phatak, Robert S. Britton & Bruce R. Bacon. 2011. Handbook of Iron Overload Disorders. Handbook of Iron Overload Disorders 342 346 .
James C. Barton, Corwin Q. Edwards, Pradyumna D. Phatak, Robert S. Britton & Bruce R. BaconJames C. Barton, Corwin Q. Edwards, Pradyumna D. Phatak, Robert S. Britton & Bruce R. Bacon. 2011. Handbook of Iron Overload Disorders. Handbook of Iron Overload Disorders 127 148 .
James C. Barton, Corwin Q. Edwards, Pradyumna D. Phatak, Robert S. Britton & Bruce R. BaconJames C. Barton, Corwin Q. Edwards, Pradyumna D. Phatak, Robert S. Britton & Bruce R. Bacon. 2011. Handbook of Iron Overload Disorders. Handbook of Iron Overload Disorders 65 107 .
. (2010) EASL clinical practice guidelines for HFE hemochromatosis. Journal of Hepatology 53:1, pages 3-22.
Crossref
MF Aslam, K Vemareddy, ZO Merhi & H Minkoff. (2010) Unusual case of postpartum hepatitis due to hereditary haemochromatosis. BJOG: An International Journal of Obstetrics & Gynaecology 117:5, pages 620-622.
Crossref
K. Sigvard Olsson, Bernd Ritter & Ruma Raha‐Chowdhury. (2010) HLA‐A3‐B14 and the origin of the haemochromatosis C282Y mutation: founder effects and recombination events during 12 generations in a Scandinavian family with major iron overload. European Journal of Haematology 84:2, pages 145-153.
Crossref
Eng K. Gan, Oyekoya T. Ayonrinde, Debbie Trinder & John K. Olynyk. (2010) Phenotypic Expression of Hereditary Hemochromatosis: What Have We Learned from the Population Studies?. Current Gastroenterology Reports 12:1, pages 7-12.
Crossref
Kristina M. Utzschneider & Kris V. Kowdley. (2010) Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nature Reviews Endocrinology 6:1, pages 26-33.
Crossref
James C. Barton, Corwin Q. Edwards, Pradyumna D. Phatak, Robert S. Britton & Bruce R. Bacon. 2010. Handbook of Iron Overload Disorders. Handbook of Iron Overload Disorders 1 9 .
Min Tao & David L Pelletier. (2009) The effect of dietary iron intake on the development of iron overload among homozygotes for haemochromatosis. Public Health Nutrition 12:10, pages 1823-1829.
Crossref
Jill WaalenErnest Beutler. (2009) Genetic Screening for Low-Penetrance Variants in Protein-Coding Genes. Annual Review of Genomics and Human Genetics 10:1, pages 431-450.
Crossref
Marnie J. Wood, Richard Skoien & Lawrie W. Powell. (2009) The global burden of iron overload. Hepatology International 3:3, pages 434-444.
Crossref
Albert Altès, Vanessa Bach, Angels Ruiz, Anna Esteve, Angel F. Remacha, M. Pilar Sardà, Jordi Felez & Montserrat Baiget. (2008) Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?. Annals of Hematology 88:4, pages 341-345.
Crossref
Einar Skulstad Davidsen, Tor Hervig, Per Omvik & Eva Gerdts. (2008) Left ventricular long-axis function in treated haemochromatosis. The International Journal of Cardiovascular Imaging 25:3, pages 237-247.
Crossref
Tore Bjerke. (2009) Transferrinmetning ikke screeningtest alene. Tidsskrift for Den norske legeforening 129:22, pages 2387-2388.
Crossref
Tor-Arne Hagve, Arne Åsberg, Rune Ulvik, Berit Borch-Iohnsen & Ketil Thorstensen. (2009) Hemokromatose – fra underdiagnostisert kuriositet til folkesykdom. Tidsskrift for Den norske legeforening 129:9, pages 863-866.
Crossref
Berit Borch-Iohnsen, Tor-Arne Hagve, Anton Hauge & Ketil Thorstensen. (2009) Regulering av jernbalansen. Tidsskrift for Den norske legeforening 129:9, pages 858-862.
Crossref
Gordon D. McLaren & Victor R. Gordeuk. (2009) Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Hematology 2009:1, pages 195-206.
Crossref
Esther M.G. Jacobs, Jan C.M. Hendriks, Cees Th.B.M. van Deursen, Herman G. Kreeftenberg, Richard A. de Vries, Joannes J.M. Marx, Anton F.H. Stalenhoef, André L.M. Verbeek & Dorine W. Swinkels. (2009) Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: The HEmochromatosis FAmily Study. Journal of Hepatology 50:1, pages 174-183.
Crossref
Sabine J. Presser. 2008. Hereditary Tumors. Hereditary Tumors 355 376 .
Lyle C. Gurrin, Nicholas J. Osborne, Clare C. Constantine, Christine E. McLaren, Dallas R. English, Dorota M. Gertig, Martin B. Delatycki, Melissa C. Southey, John L. Hopper, Graham G. Giles, Gregory J. Anderson, John K. Olynyk, Laurie W. Powell & Katrina J. Allen. (2008) The Natural History of Serum Iron Indices for HFE C282Y Homozygosity Associated With Hereditary Hemochromatosis. Gastroenterology 135:6, pages 1945-1952.
Crossref
John K. Olynyk, Debbie Trinder, Grant A. Ramm, Robert S. Britton & Bruce R. Bacon. (2008) Hereditary hemochromatosis in the post- HFE era . Hepatology 48:3, pages 991-1001.
Crossref
M. A. McCullen, L. M. Fletcher, G. Dimeski, A. Pink, L. W. Powell, D. H. G. Crawford & P. E. Hickman. (2008) Patient‐focused outcomes following detection in a hospital‐based screening programme for C282Y haemochromatosis. Internal Medicine Journal 38:8, pages 651-656.
Crossref
K. Sigvard Olsson, Bernd Ritter, Norbeth Hansson & Ruma R. Chowdhury. (2008) HLA haplotype map of river valley populations with hemochromatosis traced through five centuries in Central Sweden. European Journal of Haematology 81:1, pages 36-46.
Crossref
James S. Pankow, Eric Boerwinkle, Paul C. Adams, Eliseo Guallar, Catherine Leiendecker-Foster, Jason Rogowski & John H. Eckfeldt. (2008) HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study. Translational Research 152:1, pages 3-10.
Crossref
Pierre Brissot, Marie-Bérengère Troadec, Edouard Bardou-Jacquet, Caroline Le Lan, Anne-Marie Jouanolle, Yves Deugnier & Olivier Loréal. (2008) Current approach to hemochromatosis. Blood Reviews 22:4, pages 195-210.
Crossref
Melanie Beaton & Paul C. Adams. (2008) Assessment of Silent Liver Fibrosis in Hemochromatosis C282Y Homozygotes With Normal Transaminase Levels. Clinical Gastroenterology and Hepatology 6:6, pages 713-714.
Crossref
Marnie J. Wood, Lawrie W. Powell & Grant A. Ramm. (2008) Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood 111:9, pages 4456-4462.
Crossref
Stuart Watkins, Douglas Thorburn, Neeraj Joshi, Margaret Neilson, Theresa Joyce, Richard Spooner, Alexander Cooke, Peter R. Mills, A. John Morris & Adrian J. Stanley. (2008) The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing. European Journal of Gastroenterology & Hepatology 20:5, pages 379-383.
Crossref
Jill Waalen, Vincent J. Felitti, Terri Gelbart & Ernest Beutler. (2008) Response: Screening for treatable disease is better than just screening for hemochromatosis. Blood 111:7, pages 3897-3897.
Crossref
Arne Åsberg, Ketil Thorstensen, Wenche Irgens & Kristian Hveem. (2008) Screening for hemochromatosis. Blood 111:7, pages 3896-3896.
Crossref
Jill Waalen, Vincent J. Felitti, Terri Gelbart & Ernest Beutler. (2008) Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood 111:7, pages 3373-3376.
Crossref
Bruce R. Bacon & Robert S. Britton. (2008) Clinical Penetrance of Hereditary Hemochromatosis. New England Journal of Medicine 358:3, pages 291-292.
Crossref
Alberto PipernoDomenico GirelliElizabeta Nemeth, Paola TrombiniClaudia BozziniErika Poggiali, Yen Phung, Tomas Ganz & Clara Camaschella. (2007) Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 110:12, pages 4096-4100.
Crossref
Paul C Adams & James C Barton. (2007) Haemochromatosis. The Lancet 370:9602, pages 1855-1860.
Crossref
K. Sigvard Olsson, Bernd Ritter & Norbeth Hansson. (2007) The HLA‐A1‐B8 haplotype hitchhiking with the hemochromatosis mutation: does it affect the phenotype?. European Journal of Haematology 79:5, pages 429-434.
Crossref
Paul C. Adams, David M. Reboussin, Richard D. Press, James C. Barton, Ronald T. Acton, Godfrey C. Moses, Catherine Leiendecker-Foster, Gordon D. McLaren, Fitzroy W. Dawkins, Victor R. Gordeuk, Laura Lovato & John H. Eckfeldt. (2007) Biological Variability of Transferrin Saturation and Unsaturated Iron-Binding Capacity. The American Journal of Medicine 120:11, pages 999.e1-999.e7.
Crossref
S. J. Fairweather-Tait, L. Harvey, A.-L. M. Heath & M. Roe. (2007) Effect of SNPs on iron metabolism. Genes & Nutrition 2:1, pages 15-19.
Crossref
Oyekoya T. Ayonrinde & John K. Olynyk. (2007) Clinical expression of hemochromatosis gene (HFE) variants. Hepatology 46:4, pages 960-962.
Crossref
James C. BartonRonald T. ActonCatherine Leiendecker-FosterLaura LovatoPaul C. AdamsGordon D. McLarenJohn H. EckfeldtChristine E. McLarenDavid M. ReboussinVictor R. GordeukMark R. SpeechleyJacob A. ReissRichard D. PressFitzroy W. Dawkins. (2007) HFE C282Y Homozygotes Aged 25–29 Years at HEIRS Study Initial Screening . Genetic Testing 11:3, pages 269-275.
Crossref
Antonello Pietrangelo. 2007. Textbook of Hepatology. Textbook of Hepatology 1323 1329 .
Einar Skulstad Davidsen, Knut Liseth, Per Omvik, Tor Hervig & Eva Gerdts. (2016) Reduced exercise capacity in genetic haemochromatosis. European Journal of Cardiovascular Prevention & Rehabilitation 14:3, pages 470-475.
Crossref
Eva Rombout-Sestrienkova, Paulus A.H. van Noord, Cees Th.B.M. van Deursen, Bob J.P.H. Sybesma, Ans E.L. Nillesen-Meertens & Ger H. Koek. (2007) Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis – A pilot study. Transfusion and Apheresis Science 36:3, pages 261-267.
Crossref
G Gagné, D Reinharz, N Laflamme, PC Adams & F Rousseau. (2006) Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost‐effectiveness of testing algorithms. Clinical Genetics 71:1, pages 46-58.
Crossref
James C Barton, Ellen H Barton & Ronald T Acton. (2006) Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFEC282Y homozygosity. BMC Medical Genetics 7:1.
Crossref
Alissa Walsh, Jeannette L. Dixon, Grant A. Ramm, David G. Hewett, Douglas J. Lincoln, Gregory J. Anderson, V. Nathan Subramaniam, Julian Dodemaide, Juleen A. Cavanaugh, Mark L. Bassett & Lawrie W. Powell. (2006) The Clinical Relevance of Compound Heterozygosity for the C282Y and H63D Substitutions in Hemochromatosis. Clinical Gastroenterology and Hepatology 4:11, pages 1403-1410.
Crossref
Antonello Pietrangelo. (2006) Hereditary Hemochromatosis. Annual Review of Nutrition 26:1, pages 251-270.
Crossref
Paul C. Adams, Leah Passmore, Subrata Chakrabarti, David M. Reboussin, Ronald T. Acton, James C. Barton, Gordon D. McLaren, John H. Eckfeldt, Fitzroy W. Dawkins, Victor R. Gordeuk, Emily L. Harris, Catherine Leiendecker–Foster, Elaine Gossman & Phyliss Sholinsky. (2006) Liver Diseases in the Hemochromatosis and Iron Overload Screening Study. Clinical Gastroenterology and Hepatology 4:7, pages 918-923.e1.
Crossref
Eugénia Cruz, Graça Melo, Rosa Lacerda, Susana Almeida & Graça Porto. (2006) The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: An update of clinical and immunological data from 70 C282Y homozygous subjects. Blood Cells, Molecules, and Diseases 37:1, pages 33-39.
Crossref
P. C. ADAMS. (2006) Review article: the modern diagnosis and management of haemochromatosis. Alimentary Pharmacology & Therapeutics 23:12, pages 1681-1691.
Crossref
Ketil Thorstensen & Arne Åsberg. (2006) Transferrin saturation should not be corrected for body mass index in screening studies for haemochromatosis. Journal of Hepatology 44:5, pages 1003-1004.
Crossref
J. Leyden, B. Kelleher, E. Ryan, S. Barrett, J. C. O’Keane & J. Crowe. (2006) The Celtic coincidence — the frequency and clinical characterisation of hereditary haemochromatosis in patients with coeliac disease. Irish Journal of Medical Science 175:1, pages 32-36.
Crossref
Ernest Beutler. (2006) Hemochromatosis: Genetics and Pathophysiology. Annual Review of Medicine 57:1, pages 331-347.
Crossref
Ernest Beutler. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Paolo Del Poggio. (2006) Screening in liver disease. World Journal of Gastroenterology 12:33, pages 5272.
Crossref
Rodolfo Delfini Cançado, Aline Cristiane de Oliveira Guglielmi, Carmen Silvia Vieitas Vergueiro, Ernani Geraldo Rolim, Maria Stella Figueiredo & Carlos Sérgio Chiattone. (2006) Analysis of HFE gene mutations and HLA-A alleles in Brazilian patients with iron overload. Sao Paulo Medical Journal 124:2, pages 55-60.
Crossref
Daphne L. van der A, Petra H.M. Peeters, Diederick E. Grobbee, Mark Roest, Hieronymus A.M. Voorbij & Yvonne T. van der Schouw. (2006) HFE genotypes and dietary heme iron: No evidence of strong gene–nutrient interaction on serum ferritin concentrations in middle-aged women. Nutrition, Metabolism and Cardiovascular Diseases 16:1, pages 60-68.
Crossref
Paul C. Adams. 2006. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 1239 1256 .
Gérald Le Gac & Claude Férec. (2005) The molecular genetics of haemochromatosis. European Journal of Human Genetics 13:11, pages 1172-1185.
Crossref
Jill Waalen & Ernest Beutler. (2005) Beware of multiple comparisons: A study of symptoms associated with mutations of the HFE hemochromatosis gene. Clinica Chimica Acta 361:1-2, pages 128-134.
Crossref
Carolina Gómez-Llorente, M. Teresa Miranda-León, Sonia Blanco, Sandra Gandia-Pla, Jose Antonio Gómez-Capilla & M. Esther Fárez-Vidal. (2005) Frequency and clinical expression of HFE gene mutations in a Spanish population of subjects with abnormal iron metabolism. Annals of Hematology 84:10, pages 650-655.
Crossref
Manfred StuhrmannLudwig HoyIrmgard NippertJörg Schmidtke. (2005) Genotype-based Screening for Hereditary Hemochromatosis: II. Attitudes Toward Genetic Testing and Psychosocial Impact—A Report from a German Pilot Study. Genetic Testing 9:3, pages 242-254.
Crossref
James C. BartonRonald T. ActonFitzroy W. DawkinsPaul C. AdamsLaura LovatoCathie Leiendecker-FosterChristine E. McLarenDavid M. ReboussinMark R. SpeechleyVictor R. GordeukGordon D. McLarenPhyliss SholinskyEmily L. Harris. (2005) Initial Screening Transferrin Saturation Values, Serum Ferritin Concentrations, and HFE Genotypes in Whites and Blacks in the Hemochromatosis and Iron Overload Screening Study . Genetic Testing 9:3, pages 231-241.
Crossref
Chiang W. Siah, Debbie Trinder & John K. Olynyk. (2005) Iron overload. Clinica Chimica Acta 358:1-2, pages 24-36.
Crossref
John K. Olynyk, Debbie Trinder & Elizabeth Milward. (2005) Hereditary haemochromatosis: To screen or not to screen?. Journal of Hepatology 43:1, pages 9-10.
Crossref
Paul C Adams. (2005) Screening for haemochromatosis—producing or preventing illness?. The Lancet 366:9482, pages 269-271.
Crossref
Paul C Adams, David M Reboussin, Cathie Leiendecker-Foster, Godfrey C Moses, Gordon D McLaren, Christine E McLaren, Fitzroy W Dawkins, Ishmael Kasvosve, Ron T Acton, James C Barton, Dan Zaccaro, Emily L Harris, Richard Press, Henry Chang & John H Eckfeldt. (2005) Comparison of the Unsaturated Iron-Binding Capacity with Transferrin Saturation as a Screening Test to Detect C282Y Homozygotes for Hemochromatosis in 101 168 Participants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Clinical Chemistry 51:6, pages 1048-1052.
Crossref
Paul C. Adams, David M. Reboussin, James C. Barton, Christine E. McLaren, John H. Eckfeldt, Gordon D. McLaren, Fitzroy W. Dawkins, Ronald T. Acton, Emily L. Harris, Victor R. Gordeuk, Catherine Leiendecker-Foster, Mark Speechley, Beverly M. Snively, Joan L. Holup, Elizabeth Thomson & Phyliss Sholinsky. (2005) Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population. New England Journal of Medicine 352:17, pages 1769-1778.
Crossref
John K. Olynyk, Timothy G. St. Pierre, Robert S. Britton, Elizabeth M. Brunt & Bruce R. Bacon. (2005) Duration of Hepatic Iron Exposure Increases the Risk of Significant Fibrosis in Hereditary Hemochromatosis: A New Role for Magnetic Resonance Imaging. The American Journal of Gastroenterology 100:4, pages 837-841.
Crossref
Manfred Stuhrmann, Christian Strassburg & Jörg Schmidtke. (2004) Genotype-based screening for hereditary haemochromatosis. I: Technical performance, costs and clinical relevance of a German pilot study. European Journal of Human Genetics 13:1, pages 69-78.
Crossref
L. W. Powell. 2005. Gastroenterology Yesterday — Today — Tomorrow: A Review and Preview. Gastroenterology Yesterday — Today — Tomorrow: A Review and Preview 135 147 .
LAWRIE W POWELL. (2004) Recent concepts in iron metabolism and HFE mutations. Journal of Gastroenterology and Hepatology 19:s7.
Crossref
Gary Jeffrey & Paul C Adams. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology 405 413 .
. (2004) Opinion of the Scientific Panel on Dietetic products, nutrition and allergies [NDA] related to the Tolerable Upper Intake Level of Iron. EFSA Journal 2:11, pages 125.
Crossref
Paul C. Adams. (2004) Hemochromatosis. Clinics in Liver Disease 8:4, pages 735-753.
Crossref
F Gleeson, E Ryan, S Barrett & J Crowe. (2004) Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. European Journal of Gastroenterology & Hepatology 16:9, pages 859-863.
Crossref
Paul C Adams. (2004) Haemochromatosis. European Journal of Gastroenterology & Hepatology 16:9, pages 857-858.
Crossref
S. DuBois & K. V. Kowdley. (2004) Targeted screening for hereditary haemochromatosis in high‐risk groups. Alimentary Pharmacology & Therapeutics 20:1, pages 1-14.
Crossref
Heinz Zoller & Wolfgang Vogel. (2004) Iron supplementation in athletes—first do no harm. Nutrition 20:7-8, pages 615-619.
Crossref
Thomas Kelleher, Eleanor Ryan, Sharon Barrett, Conor O'Keane & John Crowe. (2004) DMT1 genetic variability is not responsible for phenotype variability in hereditary hemochromatosis. Blood Cells, Molecules, and Diseases 33:1, pages 35-39.
Crossref
Wylie Burke. (2004) Clinical Validity and Clinical Utility of Genetic Tests. Current Protocols in Human Genetics 42:1.
Crossref
Antonello Pietrangelo. (2004) Hereditary Hemochromatosis — A New Look at an Old Disease. New England Journal of Medicine 350:23, pages 2383-2397.
Crossref
Kris V. Kowdley. (2004) Liver transplantation: An ?in vivo? model for the pathophysiology of hemochromatosis?. Hepatology 39:6, pages 1495-1498.
Crossref
Paul C. Adams, Michael J. Arthur, Thomas D. Boyer, Laurie D. DeLeve, Adrian M. Di Bisceglie, Mark Hall, Theodore R. Levin, Dawn Provenzale & Leonard Seeff. (2004) Screening in liver disease: Report of an AASLD clinical workshop. Hepatology 39:5, pages 1204-1212.
Crossref
Rolf Værn AndersenAnne Tybjærg-HansenMerete AppleyardHenrik BirgensBørge Grønne Nordestgaard. (2004) Hemochromatosis mutations in the general population: iron overload progression rate. Blood 103:8, pages 2914-2919.
Crossref
John K. Olynyk, Simone E. Hagan, Digby J. Cullen, John Beilby & Davina E. Whittall. (2004) Evolution of Untreated Hereditary Hemochromatosis in the Busselton Population: A 17-Year Study. Mayo Clinic Proceedings 79:3, pages 309-313.
Crossref
A. Pardo, E. Quintero, Y. Barrios, M. Bruguera, L. Rodrigo, C. Vila, D. Acero, C. Guarner, S. Pascual, L. López, R. Moreno, E. Fábrega, R. Andrade, G. Peláez, J. Santos, M. Buti & M. Torres. (2004) Genotipo y expresión fenotípica de la hemocromatosis hereditaria en España. Gastroenterología y Hepatología 27:8, pages 437-443.
Crossref
Sumedha P. Galhenage, Charlie H. Viiala & John K. Olynyk. (2004) Screening for hemochromatosis: Patients with liver disease, families, and populations. Current Gastroenterology Reports 6:1, pages 44-51.
Crossref
A. Burroughs & D. McNamara. (2003) Liver disease in Europe. Alimentary Pharmacology & Therapeutics 18:s3, pages 54-59.
Crossref
M. Födinger & G. Sunder‐Plassmann. (2003) Low clinical penetrance of homozygosity for HFE C282Y: implications for genetic testing? . European Journal of Clinical Investigation 33:9, pages 737-739.
Crossref
Linda M Fletcher, Kim R Bridle & Darrell H.G Crawford. (2003) Effect of alcohol on iron storage diseases of the liver. Best Practice & Research Clinical Gastroenterology 17:4, pages 663-677.
Crossref
Gérard Chalès & Pascal Guggenbuhl. (2003) When and how should we screen for hereditary hemochromatosis?. Joint Bone Spine 70:4, pages 263-270.
Crossref
Kymberley Carter, Derrick J. Bowen, C. Anne McCune & Mark Worwood. (2003) Haptoglobin type neither influences iron accumulation in normal subjects nor predicts clinical presentation in HFE C282Y haemochromatosis: phenotype and genotype analysis. British Journal of Haematology 122:2, pages 326-332.
Crossref
George N. Ioannou & Kris V. Kowdley. (2003) Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?. Clinical Gastroenterology and Hepatology 1:4, pages 246-248.
Crossref
Gérard Chalès & Pascal Guggenbuhl. (2003) Quand et comment dépister une hémochromatose génétique ?. Revue du Rhumatisme 70:7, pages 573-581.
Crossref
Mayka Sánchez, Margarita Villa, Mercedes Ingelmo, Cristina Sanz, Miquel Bruguera, Carlos Ascaso & Rafael Oliva. (2003) Population screening for hemochromatosis: a study in 5370 Spanish blood donors. Journal of Hepatology 38:6, pages 745-750.
Crossref
Richard S. Ajioka & James P. Kushner. (2003) Rebuttal to Beutler. Blood 101:9, pages 3358-3358.
Crossref
Ernest Beutler. (2003) Rebuttal to Ajioka and Kushner. Blood 101:9, pages 3354-3357.
Crossref
Richard S. AjiokaJames P. Kushner. (2003) Clinical consequences of iron overload in hemochromatosis homozygotes. Blood 101:9, pages 3351-3353.
Crossref
Ernest Beutler. (2003) The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood 101:9, pages 3347-3350.
Crossref
G Ioannou. (2003) Racial differences in the relationship between hepatitis C infection and iron stores. Hepatology 37:4, pages 795-801.
Crossref
Ernest Beutler, A. Victor Hoffbrand & James D. Cook. (2003) Iron Deficiency and Overload. Hematology 2003:1, pages 40-61.
Crossref
Anne Guillygomarc'h, Jacquelinet Christian, Moirand Romain, Quentin Vincent, David Véronique & Yves Deugnier. (2003) Circadian variations of transferrin saturation levels in iron‐overloaded patients: implications for the screening of C282Y‐linked haemochromatosis. British Journal of Haematology 120:2, pages 359-363.
Crossref
Stephen A Harrison & Bruce R Bacon. (2003) Hereditary hemochromatosis: update for 2003. Journal of Hepatology 38, pages 14-23.
Crossref
Wylie Burke. (2002) Genetic Testing. New England Journal of Medicine 347:23, pages 1867-1875.
Crossref
LEON EISENBERG. (2002) Is Biology Destiny? Is It All in Our Genes?. Journal of Psychiatric Practice 8:6, pages 337-343.
Crossref
Adrian Bomford. (2002) Genetics of haemochromatosis. The Lancet 360:9346, pages 1673-1681.
Crossref
Jill Waalen, Vincent Felitti, Terri Gelbart, Ngoc J. Ho & Ernest Beutler. (2002) Penetrance of Hemochromatosis. Blood Cells, Molecules, and Diseases 29:3, pages 418-432.
Crossref
Peter Nielsen, Rainer Engelhardt, Jochen Düllmann & Roland Fischer. (2002) Non-Invasive Liver Iron Quantification by SQUID-Biosusceptometry and Serum Ferritin Iron as New Diagnostic Parameters in Hereditary Hemochromatosis. Blood Cells, Molecules, and Diseases 29:3, pages 451-458.
Crossref
Ernest Beutler. (2002) History of Iron in Medicine. Blood Cells, Molecules, and Diseases 29:3, pages 297-308.
Crossref
Richard S. Ajioka & James P. Kushner. (2002) Hereditary hemochromatosis. Seminars in Hematology 39:4, pages 235-241.
Crossref
Yves Deugnier, Anne‐Marie Jouanolle, Jacques Chaperon, Romain Moirand, Catherine Pithois, Jean‐François Meyer, Michel Pouchard, Bernard Lafraise, Alain Brigand, Céline Caserio‐Schoenemann, Jean Mosser, Paul Adams, Jean‐Yves Le Gall & Véronique David. (2002) Gender‐specific phenotypic expression and screening strategies in C282Y‐linked haemochromatosis: a study of 9396 French people. British Journal of Haematology 118:4, pages 1170-1178.
Crossref
Ernest Beutler, Vincent Felitti, James A Koziol & Terri Gelbart. (2002) Clinical haemochromatosis in HFE mutation carriers. The Lancet 360:9330, pages 413-414.
Crossref

Displaying 200 of 204 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.